SILO PHARMA, INC. Prepaid Expense and Other Assets, Current
SILO PHARMA, INC. (SILO) had Prepaid Expense and Other Assets, Current of $280.87 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-13
- 2026-06-30: Prepaid Expense and Other Assets, Current $280.87K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $529.39K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $208.56K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $225.88K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $280.87K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $529.39K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $208.56K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $225.88K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $113.06K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $208.56K 10-Q · filed 2026-05-14 | $152.73K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $30.96K POS AM · filed 2026-04-14 | |
| 2024-09-30 | $246.45K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $120.29K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $133.76K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $15.97K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $79.91K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $121.33K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $204.35K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $135.89K 10-K · filed 2024-03-25 | |
| 2022-09-30 | $581.37K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $99.94K 10-Q · filed 2022-08-01 | |
| 2022-03-31 | $206.45K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $145.32K 10-K · filed 2023-03-24 | |
| 2021-09-30 | $220.59K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $167.59K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $230.41K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $241.09K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $310.98K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $525.34K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $29.37K 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $16.33K 10-K/A · filed 2021-05-17 | |
| 2019-09-30 | $23.56K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $39.42K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $40.31K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $34.03K 10-K · filed 2020-03-20 | |
| 2017-12-31 | $26.57K 10-K · filed 2019-04-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |